Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10415 (
Bcl-2
)
33,771
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
14-3-3 epsilon protein
was identified as one of the caspase-3 substrates by the modified yeast two-hybrid system. The cellular
14-3-3 epsilon protein
was also cleaved in response to the treatment of apoptosis inducers in cultured mammalian cells. Asp238 of the
14-3-3 epsilon protein
was determined as the site of cleavage by caspase-3. The affinity of the cleaved 14-3-3 mutant protein (D238) to Bad, a death-promoting
Bcl-2
family protein, was lower than that of wild type or the uncleavable mutant
14-3-3 epsilon protein
(D238A). However, Bad associated with the cellular Bcl-x(L) more effectively in human 293T cells co-expressing Bad with the truncated form of the
14-3-3 epsilon protein
(D238) than in control cells co-expressing Bad with wild type or the uncleavable mutant
14-3-3 epsilon protein
(D238A). The present study suggests that the cleavage of 14-3-3 protein during apoptosis promotes cell death by releasing the associated Bad from the 14-3-3 protein and facilitates Bad translocation to the mitochondria and its interaction with Bcl-x(L).
...
PMID:Cleavage of 14-3-3 protein by caspase-3 facilitates bad interaction with Bcl-x(L) during apoptosis. 1265 44